The low-cost fitness operator, The Gym Group, has delivered impressive financial results for the year ending December 2024, surpassing market expectations and setting the stage for accelerated expansion plans. Membership
The low-cost fitness operator, The Gym Group, has delivered impressive financial results for the year ending December 2024, surpassing market expectations and setting the stage for accelerated expansion plans. Membership
The British tea market is witnessing a remarkable transformation as premium sparkling tea emerges as a sought-after alternative to traditional alcoholic beverages. Sales figures from the festive period indicate a
The National Health Service faces unprecedented pressure as nine hospitals across England declare critical incidents, with patients experiencing wait times of up to two days in Accident and Emergency departments.
Novo Nordisk, the Danish pharmaceutical powerhouse, has invested hundreds of thousands of pounds in sponsorship deals with major UK pharmacy chains, including Boots and Lloyds, to enhance sales of its
The UK pharmacy sector witnessed a significant wave of consolidation as nearly one in ten pharmacies were acquired through mergers and acquisitions in the 12 months to June 2024, amid
Britain’s children are facing an unprecedented health crisis as poor nutrition and rising obesity rates continue to plague the nation’s youth. Recent NHS data reveals a stark reality: one in
British pharmaceutical giant AstraZeneca has distributed approximately £45 million to Russian healthcare professionals and organisations since the outbreak of the Ukraine war, despite mounting UK military support for Kyiv. The
Critical concerns are emerging regarding the National Health Service’s operational effectiveness as it awaits Wes Streeting’s comprehensive 10-year reform plan. The Institute for Public Policy Research (IPPR) has raised significant
Danish pharmaceutical giant Novo Nordisk witnessed a staggering $100 billion erosion in market value following disappointing results from its latest obesity drug trial. The company’s shares experienced their most significant
The United Kingdom’s weight-loss medication market has witnessed an unprecedented surge, with more than 500,000 individuals now utilising revolutionary anti-obesity drugs Mounjaro and Wegovy. This dramatic increase has occurred within
Finnish health-tracking smart ring manufacturer Ōura has secured a remarkable £200 million in fresh funding, propelling its valuation to £5.2 billion—twice its 2022 value. This investment round stands as one
Leading scientists have raised grave concerns about the existential threat posed by ‘mirror life’ – artificially created bacteria that could potentially overwhelm Earth’s natural defence systems. A distinguished group of
A significant shift in consumer awareness regarding ultra-processed foods (UPFs) is emerging as the festive season approaches, with shoppers becoming increasingly conscious of their dietary choices. This heightened scrutiny comes
In a sweeping move to combat childhood obesity, the UK government has announced that its forthcoming junk food advertising ban will encompass a broader range of everyday food items, including
In a significant move towards addressing gambling-related harm, the British Labour government is preparing to implement a mandatory £100 million annual levy on gambling companies. The initiative, expected to be
The treatment of lung cancer has improved over the years, but doctors can still’t predict what patients will do following surgery. About half of the patients whose tumors were “advanced,






